Clinical Trial Update: Trigger Point Injections Versus Lidocaine Patch for Myofascial Pain in the Emergency Department [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing trigger point injections to a lidocaine patch for myofascial pain in the emergency department has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myofascial Pain Syndrome

Drugs mentioned

• Lidocaine (injectable) (lidocaine)
• Lidocaine Patch (Lidocaine)

Snippet

Sponsor: University of California, Irvine | Conditions: Myofascial Trigger Point Pain, Myofacial Pain | Phase 4 | Status: WITHDRAWN